Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Steidle

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Urology Practice|April 9, 2026
Editorial CommentaryTrevor C Hunt, Matthew Steidle, Jathin Bandari
Clinical Genitourinary Cancer|December 1, 2024
Letter to the Editor: Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder CancerKamil Malshy, Matthew Steidle, William Tabayoyong, et al.
Urology Case Reports|December 31, 2025
Xanthogranulomatous cystitis presenting as a large pelvic mass invading bladder and causing obstructive uropathy: A rare case reportVictor Sandoval, Natalie Brossard, Matthew Steidle, et al.
Cancer|June 4, 2026
Association between hyperphosphatemia and overall survival among patients with advanced urothelial cancer treated with erdafitinib in phase 2/3 clinical trialsDenzel Zhu, Matthew Steidle, Yufei Jia, et al.
The Prostate|September 10, 2025
Impact of Testosterone Recovery on Oncologic Outcomes in High-Risk, Localized Prostate CancerTrevor C Hunt, Kamil Malshy, Matthew Steidle, et al.
Clinical Genitourinary Cancer|October 12, 2025
Study Endpoint Fulfillment and FDA Approval Success in Phase III Clinical Trials of Genitourinary MalignanciesMatthew Steidle, Kamil Malshy, Trevor C Hunt, et al.
JCO Oncology Practice|July 11, 2025
Impact of Industry Collaboration on US Food and Drug Administration Approval Success in Genitourinary Malignancy Phase III Clinical TrialsKamil Malshy, Matthew Steidle, Trevor C Hunt, et al.
Translational Andrology and Urology|June 18, 2025
Shifting paradigms in the treatment of small renal massesKamil Malshy, Nicola Fazaa, Etan Eigner, et al.
Urology|June 14, 2026
Utilization and Costs Among Bladder Cancer, Other Cancer, and Non-Cancer Populations in the United StatesKamil Malshy, Kelvin Lim, Yusheng Jia, et al.
Urologia|June 27, 2025
The impact of pelvic radiotherapy on hematological toxicities in pediatric genitourinary rhabdomyosarcomaKamil Malshy, Zijing Cheng, Trevor C Hunt, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Urology Practice|April 9, 2026
Editorial CommentaryTrevor C Hunt, Matthew Steidle, Jathin Bandari
Clinical Genitourinary Cancer|December 1, 2024
Letter to the Editor: Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder CancerKamil Malshy, Matthew Steidle, William Tabayoyong, et al.
Urology Case Reports|December 31, 2025
Xanthogranulomatous cystitis presenting as a large pelvic mass invading bladder and causing obstructive uropathy: A rare case reportVictor Sandoval, Natalie Brossard, Matthew Steidle, et al.
Cancer|June 4, 2026
Association between hyperphosphatemia and overall survival among patients with advanced urothelial cancer treated with erdafitinib in phase 2/3 clinical trialsDenzel Zhu, Matthew Steidle, Yufei Jia, et al.
The Prostate|September 10, 2025
Impact of Testosterone Recovery on Oncologic Outcomes in High-Risk, Localized Prostate CancerTrevor C Hunt, Kamil Malshy, Matthew Steidle, et al.
Clinical Genitourinary Cancer|October 12, 2025
Study Endpoint Fulfillment and FDA Approval Success in Phase III Clinical Trials of Genitourinary MalignanciesMatthew Steidle, Kamil Malshy, Trevor C Hunt, et al.
JCO Oncology Practice|July 11, 2025
Impact of Industry Collaboration on US Food and Drug Administration Approval Success in Genitourinary Malignancy Phase III Clinical TrialsKamil Malshy, Matthew Steidle, Trevor C Hunt, et al.
Translational Andrology and Urology|June 18, 2025
Shifting paradigms in the treatment of small renal massesKamil Malshy, Nicola Fazaa, Etan Eigner, et al.
Urology|June 14, 2026
Utilization and Costs Among Bladder Cancer, Other Cancer, and Non-Cancer Populations in the United StatesKamil Malshy, Kelvin Lim, Yusheng Jia, et al.
Urologia|June 27, 2025
The impact of pelvic radiotherapy on hematological toxicities in pediatric genitourinary rhabdomyosarcomaKamil Malshy, Zijing Cheng, Trevor C Hunt, et al.
Pageof 2